investors can Contact the law firm for free to learn more about recovering their losses

LOS ANGELES, April 14, 2023 (GLOBE NEWSWIRE) — The law firm of Portnoy advises Sarepta Therapeutics, Inc. (“Sarepta Therapeutics” or the “Company”) SRPT Investors that the Company has launched an investigation into possible securities fraud and may be filing a class action lawsuit on behalf of investors. Sarepta investors who have lost money investing are encouraged to do so Contact Lesley Portnoy, Esq.

Investors are encouraged to contact an attorney Lesley F Portnoyby phone 844-767-8529 or E-mail: lesley@portnoylaw.comto discuss your legal rights, or Click here to join the case about www.portnoylaw.com. Portnoy Law Firm can provide a free case assessment and discuss investors’ options for making claims to recover their losses.

On March 16, 2023, Sarepta Therapeutics announced that the US FDA’s Office of Therapeutics decided to hold an Advisory Committee meeting on SRP-9001 prior to the May 29, 2023 regulatory action date. This news caused the company’s stock price to drop.

Please visit our website to verify further information and to submit your transaction information.

Portnoy Law Firm represents investors in asserting claims against companies caused by wrongdoing. The firm’s founding partner has recovered over $5.5 billion for aggrieved investors. attorney advertising. Previous results do not guarantee similar results.

Lesley F. Portnoy, Esq.
Bar Association in CA and NY
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

lawyer advertising